The Qafila journey is better together. 🐪 Binance is sharing a $5,000 USDC Reward Pool. How to participate: 1️⃣ Join any Binance Community Channel 2️⃣ Find the Qafila Survey 3️⃣ Complete all 5/5 survey tasks ⚠️ Partial completion does not count. Join & find the survey here 👇 #Binance# #Qafila2026# #BinanceCommunity# #USDC#

Travel is always better together 🤝✈️ Invite your friends to Travala with your referral link! When they sign up and complete their first booking, you both earn $50 in Bitcoin for future adventures 😍 Invite your friends now 👉

Everything is better together. Ready to take a seat? 𝘙𝘦𝘮𝘪𝘯𝘥𝘦𝘳: 𝘯𝘰𝘵𝘩𝘪𝘯𝘨 𝘪𝘴 𝘰𝘧𝘧𝘪𝘤𝘪𝘢𝘭 𝘶𝘯𝘵𝘪𝘭 𝘱𝘰𝘴𝘵𝘦𝘥 𝘧𝘳𝘰𝘮 𝘵𝘩𝘪𝘴 𝘢𝘤𝘤𝘰𝘶𝘯𝘵 𝘰𝘳 𝘰𝘯 𝘰𝘶𝘳 𝘱𝘶𝘣𝘭𝘪𝘴𝘩𝘦𝘥 𝘴𝘪𝘵𝘦. 𝘞𝘩𝘪𝘤𝘩 𝘪𝘴 𝘤𝘰𝘮𝘪𝘯𝘨 𝘣𝘦𝘧𝘰𝘳𝘦 𝘵𝘩𝘦 𝘸𝘦𝘦𝘬𝘦𝘯𝘥 🪑

Football is better together. ⚽ Here's a look back at some of our favorite community moments from the past few weeks. Which photo is your favorite? 👀👇 #WeAre26# #MEXCEventRocks#

Open + closed models = better together. Our previous research with @harvey showed the benefits of combining a frontier closed model as an advisor agent with fine-tuned, open-source worker agents. Three benchmarks later, the result holds. In an even simpler set up, the open + closed duo delivers superior outcomes and 40-67% lower cost than running entirely on Opus 4.8. Read the breakdown →

AI and crypto: rivals or better together? @lale_akoner joins @chainlink’s “Insights with Experts” on 25 September to explore how AI and blockchain could reshape capital allocation and autonomous finance. Register to the webinar here 👇

Curse of the Sea Rats is 25% OFF at the Better together sale of Humble Bundle store until December 11th! Because going on pirate adventures is even more fun with friends 💪 Get a crew of up to 4 pirates and have fun ✌ 🔗

🇯🇵🇬🇧 Three drug companies are teaming up to test whether two cancer drugs work better together. AstraZeneca and Daiichi Sankyo will pair their drug Datroway with Summit Therapeutics' ivonescimab in several cancers, including lung and breast. They'll start with a Phase III trial in triple-negative breast cancer as a first treatment. Each company supplies its own drug, shares trial costs, and keeps its own rights. The deal builds on AstraZeneca's $2 billion investment in Summit.